New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss ...

Novo Nordisk said on Monday its experimental next-generation drug CagriSema helped overweight or obese patients with type 2 ...

Novo Nordisk's obesity drug CagriSema failed to outperform Eli Lilly's Mounjaro in the latest trial, causing a dip in Novo's ...

Dr. Bhardwaj's pioneering approach has earned him widespread recognition, including the prestigious title of "World's Fastest ...

It seems like no matter what I do, I can't lose weight. Most of my family members struggle with their weight too. Do our ...

Novo Nordisk has reported the second phase 3 trial of its new obesity hopeful CagriSema but, as with the first, the topline ...

Novo Nordisk's experimental drug, CagriSema, demonstrated a 15.7% weight reduction in obese individuals with type 2 diabetes over 68 weeks. Key findings from the phase III REDEFINE 2 trial highlight ...

A new study breaks down exactly how to stop eating ultra-processed foods in eight weeks. Here's what it found and what ...

Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE programme. REDEFINE 2 is a 68-week efficacy and safety trial investigating ...

A WOMAN has revealed that she lost over 10 stone after taking Mounjaro for seven months. Alexandra, who is from the UK but is ...